Within this subset of our cohort, we found no differences in IL-1β, IL-6, or IL-8 secretion between CF subjects who were taking prescribed modulators and CF subjects who were not (Supplementary Fig. S3a–c). This evidence concerns the gene IL1B and cystic fibrosis.